Health Advocate for Children After Liver Transplant

(HEAL-Tx:RCT Trial)

Overseen By Bethany Reyna, BA, CCRP

Age: < 65

Sex: Any

Trial Phase: Academic

Sponsor: University of California, San Francisco

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

The HEAL-Tx is a 90-day intervention, in which a Health Advocate works with eligible families to identify and apply for community-based resources, alert healthcare providers to challenges the family is encountering, and guide health system navigation (e.g., coordinating appointments). Families in the control arm will receive a printed handout that provides contact information for local community-based resources. Families in the treatment arm will receive HEAL-Tx.

Who Is on the Research Team?

Sharad Wadhwani, MD, MPH

Principal Investigator

University of California, San Francisco

Are You a Good Fit for This Trial?

This trial is for families with children who have received a liver transplant. It's designed to help them navigate the healthcare system and access community resources effectively.

Inclusion Criteria

I am younger than 18 years old and need a liver transplant.

I had a liver transplant within the last 3 months.

Family endorses material economic hardship on the 10-questions Accountable Healthcare Communities screening tool

Exclusion Criteria

I have severe difficulty with thinking or memory.

I am 18 years old or older.

I am willing and able to give consent to participate.

What Are the Treatments Tested in This Trial?

Interventions

• Health Advocate

Trial Overview The study is testing a 90-day program where a Health Advocate assists families post-liver transplant versus just giving them a handout with resource contacts. The goal is to see if having personalized support makes a difference.

How Is the Trial Designed?

Group I: Health Advocate Intervention Experimental Treatment 1 Intervention

The caregiver will receive 90-days of tailored health advocate intervention

Group II: Enhanced Control Active Control 1 Intervention

The caregiver will receive a printed sheet of resources once and a follow-up call at the 45-day timepoint with a reminder of the suggested resources.

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials

2,636

Recruited

19,080,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials

2,513

Recruited

4,366,000+